Anzalone Christopher Richard (CIK 1423029) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Sell ARWR (7,416 shares), Sell ARWR (5,771 shares), Buy ARWR (35,181 shares), Buy ARWR (16,545 shares), Sell ARWR (35,181 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 7,416 | $488,566 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 5,771 | $383,137 |
| 2025-12-30 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Buy | 35,181 | $216,363 |
| 2025-12-30 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Buy | 16,545 | $101,752 |
| 2025-12-30 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 35,181 | $2.4M |
| 2025-12-30 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 16,545 | $1.1M |
| 2025-12-23 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 3,979 | $265,280 |
| 2025-12-23 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 8,147 | $554,077 |
| 2025-12-23 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 1,319 | $90,325 |
| 2025-12-23 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 10,012 | $684,120 |
| 2025-12-23 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 2,574 | $177,220 |
| 2025-12-19 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 35,750 | $2.3M |
| 2025-12-19 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 46,287 | $2.9M |
| 2025-12-19 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 982 | $64,350 |
| 2025-12-19 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 1,981 | $131,340 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Buy | 180,000 | $0 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 100,532 | $6.9M |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 21,321 | $1.5M |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 8,147 | $569,964 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 8,416 | $509,252 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 10,963 | $671,484 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 14,095 | $875,581 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 8,476 | $533,479 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 6,661 | $428,236 |
| 2025-12-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Executive Officer | Sell | 1,000 | $64,960 |
Source: SEC Form 4 filings · as of 2026-01-05